Legal Representation
Attorney
Forrest Merithew
USPTO Deadlines
Next Deadline
2143 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20251209)
Due Date
December 09, 2031
Grace Period Ends
June 09, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 9, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Dec 9, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 14, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Nov 14, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Nov 14, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| May 28, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Nov 10, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| May 28, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| May 27, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 1, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 1, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 10, 2025 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Mar 7, 2025 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 5, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 5, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 5, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 5, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 5, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Feb 25, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 24, 2025 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 24, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 7, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Retail store services featuring electrolyte drink mix, electrolyte powders, electrolyte supplements, health supplements, oxygen, glutathione supplements and drinks and thorne resveracel supplement, clothing and apparel, and iv equipment; On-line retail store services featuring electrolyte drink mix, electrolyte powders, electrolyte supplements, health supplements, oxygen, glutathione supplements and drinks and thorne resveracel supplement, clothing and apparel, and iv equipment
First Use Anywhere:
Nov 1, 2024
First Use in Commerce:
Dec 1, 2024
Class 044
Intravenous (IV) hydration therapy services; Intravenous (IV) vitamin therapy services; Medical services, namely, administering intravenous hydration and supplements; Consulting services in the field of hormone replacement therapy; Medical clinic providing weight loss solutions, services and programs, nutrition counseling, hormone therapy, including, bioidentical hormone replacement, anti aging therapy, and natural hormone therapy, medical aesthetic procedures, including, laser hair removal, laser peels, botulinum toxin treatments, microdermabrasion, liposuction, vein treatments, vein therapy, cellulite treatments, body contouring treatments, injectable filler treatments, facials, and skin care
First Use Anywhere:
Nov 1, 2024
First Use in Commerce:
Dec 1, 2024
Additional Information
Design Mark
The mark consists of a stylized droplet with a stylized mountain inside the droplet. The stacked, stylized wording "ONUS" and "IV THERAPY + LONGEVITY" appears to the right of the droplet.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
ONUS IV THERAPY PLUS LONGEVITY
Classification
International Classes
035
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"IV THERAPY + LONGEVITY"